SUBSTANTIAL REDUCTION IN CHRONIC GRAFT-VERSUS-HOST DISEASE AND ADEQUATE IMMUNE RECONSTITUTION WITH POST-TRANSPLANT CYCLOPHOSPHAMIDE IN UNRELATED DONOR TRANSPLANTATION: A COMPARATIVE CASE-CONTROL STUDY

busulfan - Generic mfg.

Prevymis (letermovir) - Merck (MSD)

cyclophosphamide - Generic mfg.

fludarabine IV - Generic mfg.

mycophenolate mofetil - Generic mfg.

thiotepa - Generic mfg.

https://library.ehaweb.org/eha/2025/eha2025-congress/4162478/antri.polyviou.substantial.reduction.in.chronic.graft-versus-host.disease.and.html?f=menu%3D6%2Abrowseby%3D8%2Asortby%3D2%2Amedia%3D3%2Ace_id%3D2882%2Aot_id%3D31555%2Amarker%3D5845%2Afeatured%3D19595

Antri Polyviou; Sotirios Bristogiannis; Athanasios Gakopoulos; Michael Panoussieris; Soultana Tryfonidou; Panagiotis Siamatas; Ioanna Venetsanaki; Eleni Porfyriou; Maria-Eleni Karatza; Eirini Grispou; Maria Garofalaki; Eirini Tziotziou; Tatiana Tzenou; Georgia Kourti; Ifigeneia Tzannou; Ioannis Tsonis; Stavros Gigantes; Ioannis Baltadakis

May 16, 2025